Survey all liver function tests โ€” bilirubin, albumin, PT, aminotransferases โ€” and their ASCP exam significance.

ASCPprep.com | Clinical Chemistry
Chapter โ€” Liver Function & Liver Disease
ASCP Board Exam ยท Lab-Focused Study Guide
Methods ยท Clinical Interpretation ยท Pre-analytical Variables ยท Practice Questions

1 ยท Priority Table & Quick Foundation

Topic Priority Why It’s Tested
Bilirubin metabolism (conjugated vs unconjugated vs delta) HIGH Core concept that links jaundice, hemolysis, and obstruction. ASCP loves bilirubin pattern questions.
Hepatocellular vs cholestatic enzyme pattern (ALT, AST, ALP, GGT) HIGH The single most clinically actionable lab pattern in chemistry.
AST/ALT ratio (De Ritis) โ€” alcoholic vs viral HIGH Ratio >2 = alcoholic; ALT>AST = viral. Classic exam discriminator.
Jaundice classification (pre/hepatic/post) HIGH Maps lab pattern โ†’ anatomic site โ†’ diagnosis.
Hepatitis serology (HAV, HBV, HCV) HIGH HBV serologic windows are heavily tested.
Bilirubin methods (Jendrassik-Grof, Malloy-Evelyn) & light sensitivity HIGH Accelerator, wavelength, and pre-analytical light/lipemia/hemolysis traps.
Ammonia โ€” pre-analytical handling HIGH RBCs contain 2โ€“3ร— plasma ammonia; ice + EDTA/heparin is mandatory.
ALP differentiation (5′-NT vs GGT vs bone fraction) MED Distinguishing hepatic ALP from bone/placental ALP is a frequent stem.
PT/INR and vitamin K trial MED Vit K corrects cholestatic coagulopathy but NOT hepatocellular failure.
Inherited disorders (Gilbert, Crigler-Najjar, Dubin-Johnson, Rotor) MED Each has a unique bilirubin pattern โ€” easy classification questions.
Wilson disease, hemochromatosis, ฮฑ1-antitrypsin deficiency MED Inherited causes of chronic hepatitis; signature labs.
Reye syndrome (aspirin + viral illness) MED Pediatric scenario with non-icteric hyperammonemia.
HCC and ฮฑ-fetoprotein MED Tumor marker classic.
Bile acid synthesis details LOW Mechanistic background โ€” recognize, don’t memorize.
Detailed liver lobule anatomy LOW Brief recognition only.
KEY POINT โ€” Where to spend your study time: Focus 70% of effort on the bilirubin pathway, the four-enzyme pattern (ALT/AST/ALP/GGT), and HBV serology. Skim the bile-acid biosynthesis pathway and detailed acinus zonation โ€” the exam tests the lab pattern, not the cholesterol numbering.

Quick Foundation โ€” explained from zero

  • The liver is the body’s main metabolic factory, detox plant, and protein synthesizer.
  • Hepatocytes (โ‰ˆ80% of liver mass) do the work; Kupffer cells (sinusoidal macrophages) clean the blood.
  • When liver cells are injured, cytoplasmic enzymes (ALT, AST) leak into blood.
  • When bile flow is blocked, membrane enzymes (ALP, GGT) plus conjugated bilirubin back up into blood.
  • When liver cells are failing (synthetic loss), albumin falls and PT/INR rises.
  • Bilirubin = the orange waste of red blood cell breakdown. The liver conjugates it (water-soluble) so it can be excreted in bile.
  • Where the bilirubin pathway breaks tells you where the disease is: prehepatic (hemolysis), hepatic (cell), or posthepatic (duct).
Analogy: Think of the liver as a factory with three failure modes โ€” leaky pipes (hepatocellular: AST/ALT spill out), blocked drain (cholestatic: ALP/GGT back up), and failing machinery (synthetic failure: albumin/PT drop).

Why this matters clinically: A single liver-function panel tells you whether the problem is hepatocyte injury, bile flow obstruction, or end-stage failure โ€” and that drives every downstream test.

Concept Plain-English Explanation
Unconjugated bilirubin “Raw” bilirubin โ€” water-insoluble, ride on albumin, NOT in urine.
Conjugated bilirubin “Processed” bilirubin โ€” water-soluble, can appear in urine when blood levels rise.
Delta bilirubin Conjugated bilirubin covalently stuck to albumin; lingers because albumin’s half-life is ~3 weeks.
ALT vs AST ALT lives mostly in liver = more specific. AST lives in liver, heart, muscle = less specific.
ALP Lining of bile canaliculi โ†’ rises in cholestasis. Also from bone, intestine, placenta.
GGT Microsomal enzyme; rises in cholestasis AND from alcohol/drug induction. NOT in bone.
Albumin Longest-living liver protein (~21 days); low only in chronic liver disease.
PT / INR Most sensitive marker of acute synthetic failure; factors II, VII, IX, X are vitamin Kโ€“dependent.

2 ยท Core Content โ€” Analytes & Enzymes

Bilirubin

Feature Details
Definition Orange-yellow heme breakdown pigment; ~200โ€“300 mg produced/day, mainly from senescent RBCs.
Source Reticuloendothelial system (spleen, marrow) โ†’ bound to albumin โ†’ liver.
Conjugation In hepatocyte by UDP-glucuronyl transferase (UGT1A1) โ†’ bilirubin diglucuronide (water-soluble).
Normal range (adult) Total 0.2โ€“1.0 mg/dL ยท Conjugated (direct) 0.0โ€“0.2 mg/dL ยท Unconjugated 0.2โ€“0.8 mg/dL.
Visible jaundice โ‰ฅ3.0 mg/dL (skin/sclera).
Kernicterus threshold (neonate) ~20 mg/dL unconjugated โ€” risk of basal-ganglia deposition.
Mechanism of elevation โ†‘ Indirect = overproduction (hemolysis) or impaired conjugation. โ†‘ Direct = excretion defect (hepatocyte or duct).
Methods Jendrassik-Grof (caffeine-benzoate accelerator, reads at 600 nm, blue azobilirubin) โ€” reference method. Malloy-Evelyn (methanol accelerator, reads at 560 nm, red-purple azobilirubin, pH 1.2).
Reagent Diazotized sulfanilic acid โ†’ splits bilirubin at central methylene carbon โ†’ two azobilirubin molecules.
Direct vs Total Direct = without accelerator (only conjugated reacts). Total = with accelerator (all fractions react). Indirect = Total โˆ’ Direct.

Bilirubin’s reactivity depends on solubility: conjugated bilirubin reacts directly with diazo reagent; unconjugated needs an accelerator (caffeine-benzoate or methanol) to solubilize it first.

PRE-ANALYTICAL โ€” Bilirubin:

  • Light-sensitive: values drop 30โ€“50% per hour in light. Wrap or keep in dark.
  • Hemolysis: decreases the diazo reaction โ†’ falsely low bilirubin.
  • Lipemia: falsely increases bilirubin (Malloy-Evelyn especially).
  • Fasting sample preferred; serum or plasma.
  • Storage: 2 days at room temp (dark), 1 wk at 4 ยฐC, indefinite at โˆ’20 ยฐC.
  • Bromocresol green for albumin overestimates at low values; bromocresol purple falsely low in jaundice (bilirubin competes).

Aminotransferases โ€” ALT and AST

Feature ALT (SGPT) AST (SGOT)
Reaction Alanine + ฮฑ-KG โ†’ pyruvate + glutamate Aspartate + ฮฑ-KG โ†’ oxaloacetate + glutamate
Tissue distribution Mainly liver (some kidney, muscle) Heart, muscle, liver, kidney, RBC
Liver specificity HIGH LOW
Subcellular location Cytosolic only Cytosolic + mitochondrial
Plasma half-life โ‰ˆ47 hours โ‰ˆ17 hours
Mechanism of elevation Hepatocyte injury โ†’ cell membrane leakage Hepatocyte injury + extrahepatic muscle injury
Pattern in viral hepatitis Often 10โ€“100ร— ULN; ALT > AST Elevated but less than ALT
Pattern in alcoholic hepatitis Modest rise (rarely >300 U/L) Higher than ALT โ†’ AST/ALT > 2 (De Ritis ratio)
Pattern in acetaminophen/ischemia Very high (>100ร— ULN) AST > ALT initially
EXAM TIP โ€” De Ritis ratio: AST/ALT > 2 = alcoholic liver disease (mitochondrial AST released; pyridoxal phosphate depletion limits ALT synthesis). AST/ALT < 1 = viral hepatitis, NAFLD. AST/ALT > 1 in chronic disease suggests progression to cirrhosis.
PRE-ANALYTICAL โ€” AST/ALT: Hemolysis falsely raises AST (RBCs have AST). Sample stability good at 4 ยฐC for several days.

Alkaline Phosphatase (ALP)

Feature Details
Definition Zinc metalloenzyme; hydrolyzes phosphate esters at alkaline pH.
Tissue sources Liver (canalicular membrane), bone, intestine, placenta, kidney.
Mechanism of elevation Cholestasis โ†’ bile acids solubilize canalicular membrane โ†’ ALP shed into plasma; also increased synthesis induced by bile acids.
Clinical significance โ†‘โ†‘โ†‘ in extrahepatic obstruction and intrahepatic cholestasis (e.g., PBC); modest rise in hepatitis. Also rises in Paget disease, bone mets, pregnancy (3rd trimester), childhood growth spurts.
Half-life ~1โ€“7 days (liver isoform).
Method p-Nitrophenyl phosphate substrate at alkaline pH โ†’ p-nitrophenol (yellow, read at 405 nm).
Differentiation Heat fractionation (bone is heat-labile, placenta is heat-stable), electrophoresis, or co-measure GGT or 5′-nucleotidase (both rise with hepatic ALP, neither rises with bone ALP).
PRE-ANALYTICAL โ€” ALP: EDTA and citrate chelate zinc โ†’ falsely low ALP. Use serum or lithium heparin. Hemolysis only mildly interferes.

ฮณ-Glutamyltransferase (GGT) & 5′-Nucleotidase (5′-NT)

Feature GGT 5′-NT
Tissue Kidney, liver, pancreas, prostate (NOT bone) Liver canalicular membrane (NOT bone)
Use Confirms hepatic origin of โ†‘ ALP; sensitive to alcohol & drug induction (barbiturates, phenytoin) Confirms hepatic origin of โ†‘ ALP; not induced by drugs
Mechanism Microsomal induction (alcohol, drugs) and membrane release in cholestasis Released from canalicular membrane by bile-acid action
Half-life ~4 days (longer in chronic alcohol use) โ€”
Pregnancy Not elevated Not elevated
EXAM TIP: โ†‘ ALP + โ†‘ GGT (or โ†‘ 5′-NT) โ†’ liver. โ†‘ ALP + normal GGT/5′-NT โ†’ bone, pregnancy, or growing child.

Lactate Dehydrogenase (LD)

Non-specific marker of cellular injury โ€” elevated mildly in viral hepatitis and cirrhosis. Very high LD with normal AST/ALT suggests hemolysis or liver metastases. The LDโ‚… isoenzyme is liver-specific.

Albumin and Total Protein

Feature Details
Source Exclusively hepatic synthesis.
Half-life ~21 days โ€” long, so low albumin reflects chronic disease.
Mechanism of decrease โ†“ synthesis (cirrhosis, malnutrition, IL-6 in inflammation); loss into ascites; nephrotic loss.
Clinical use Marker of chronic synthetic failure; component of Child-Pugh and MELD-Na scoring.
Method Bromocresol green (BCG, overestimates at low values) or bromocresol purple (BCP, falsely low in jaundice).

Coagulation โ€” PT / INR

Factors II, VII, IX, X (and proteins C and S) require vitamin Kโ€“dependent ฮณ-carboxylation. PT measures factors I, II, V, VII, X โ€” all hepatic.

Scenario PT change Vitamin K trial Interpretation
Cholestasis (vit K malabsorption) โ†‘ Corrects in 1โ€“2 days Synthesis intact; deficiency is dietary/absorptive.
Hepatocellular failure โ†‘ Does NOT correct Synthesis impaired โ€” poor prognostic sign.
EXAM TIP: PT is the most sensitive indicator of acute hepatic synthetic failure because factor VII has the shortest half-life (~4โ€“6 h).

Ammonia

Feature Details
Source GI tract bacterial protein breakdown.
Liver role Converted to urea (urea cycle) for renal excretion.
Mechanism of elevation End-stage liver failure (urea cycle failure), portosystemic shunting (cirrhosis), Reye syndrome (mitochondrial dysfunction), urea-cycle inborn errors.
Clinical use Diagnosis of hepatic encephalopathy and Reye syndrome; correlation with severity is weak โ€” trend is more useful than single value.
Reference range 15โ€“45 ยตg/dL (11โ€“32 ยตmol/L).
Method Glutamate dehydrogenase: NHโ‚„โบ + ฮฑ-ketoglutarate + NADPH โ†’ glutamate + NADPโบ (decrease in absorbance at 340 nm).
PRE-ANALYTICAL โ€” Ammonia (massively tested):

  • Specimen: plasma in EDTA, lithium heparin, or potassium oxalate. Never serum (clot release).
  • Ice immediately โ€” ambient temp converts amino acids to ammonia (falsely high).
  • Reject hemolyzed samples โ€” RBCs contain ammonia at 2โ€“3ร— plasma concentration.
  • Smoking, exercise, and a high-protein meal elevate ammonia โ†’ fasting, non-smoker preferred.
  • Run within 20 min or freeze at โˆ’70 ยฐC.

ฮฑ-Fetoprotein (AFP)

Fetal plasma protein; falls to adult values by age 1. Mild rise in regenerating hepatitis. Marked rise in hepatocellular carcinoma (HCC) and yolk-sac germ-cell tumors. AFP-L3 isoform is more HCC-specific. Use ALONGSIDE imaging โ€” AFP can be normal in small HCC.

Inherited and Metabolic Liver Disease โ€” Signature Labs

Disease Genetics Signature Lab Finding Mechanism
Wilson disease AR (ATP7B) โ†“ Ceruloplasmin, โ†“ serum copper, โ†‘ urine copper, ALP : bilirubin < 4, Kayser-Fleischer rings Impaired biliary copper excretion โ†’ tissue copper deposition.
Hereditary hemochromatosis AR (HFE C282Y) โ†‘ Transferrin saturation (>45%), โ†‘ ferritin Hepcidin deficiency โ†’ โ†‘ iron absorption โ†’ iron overload.
ฮฑ1-Antitrypsin deficiency AR (PiZZ) โ†“ ฮฑ1-globulin band on serum protein electrophoresis; โ†“ AAT level (<80 mg/dL) Misfolded AAT trapped in hepatocyte ER โ†’ injury.
Gilbert syndrome AR (UGT1A1 promoter TA insertion) Mild โ†‘ unconjugated bilirubin (1.5โ€“3 mg/dL); normal AST/ALT/ALP; no hemolysis UGT activity ~30 % of normal.
Crigler-Najjar I/II AR (UGT1A1) Severe unconjugated hyperbilirubinemia; kernicterus risk Absent (I) or severely reduced (II) UGT.
Dubin-Johnson AR (MRP2) โ†‘ Conjugated bilirubin; black liver on biopsy Defective canalicular excretion of conjugated bilirubin.
Rotor syndrome AR (OATP1B1/3) โ†‘ Conjugated bilirubin; liver appears normal Defective hepatic re-uptake.

Viral Hepatitis โ€” Overview

Virus Nucleic acid Incubation Transmission Chronic? Vaccine
HAV RNA (Picornavirus) 2โ€“6 wk Fecal-oral NO Yes
HBV DNA (Hepadnavirus) 8โ€“26 wk Parenteral, sexual, perinatal YES (10% adults, 90% perinatal) Yes
HCV RNA (Flavivirus) 2โ€“15 wk Parenteral YES (~80%) No
HDV RNA (defective) varies Parenteral (requires HBV) YES with HBV Indirect (HBV vaccine)
HEV RNA (Hepevirus) 3โ€“6 wk Fecal-oral NO (severe in pregnancy) No (US)

HBV Serology โ€” the high-yield grid

HBsAg Anti-HBs Anti-HBc (total) IgM Anti-HBc HBeAg Interpretation
โˆ’ โˆ’ โˆ’ โˆ’ โˆ’ Never infected, not vaccinated.
+ โˆ’ + + + Acute HBV (high infectivity).
+ โˆ’ + โˆ’ ยฑ Chronic HBV.
โˆ’ + + โˆ’ โˆ’ Recovered, immune.
โˆ’ + โˆ’ โˆ’ โˆ’ Vaccinated (no core antibody = never met whole virus).
โˆ’ โˆ’ + โˆ’ โˆ’ “Window period” OR resolved past infection OR low-level chronic.
EXAM TIP: IgM Anti-HBc is the single best marker of acute HBV (including the window when HBsAg has cleared but anti-HBs hasn’t yet appeared). HBeAg = active replication and high infectivity.

3 ยท Visual Memory Hooks

“ALT = Liver Tested” โ€” ALT is the more liver-specific aminotransferase.
“AST > ALT > 2 = ALcoholic” โ€” AST higher because alcohol releases mitochondrial AST and depletes B6 needed for ALT synthesis.
“1972 โ€” Bone-Liver-Placenta-Gut” โ€” the four organ sources of ALP, in alphabetical order.
“GGT & Gamma โ€” Grog & Gallbladder” โ€” GGT rises in alcohol and biliary obstruction; not bone or pregnancy.
“1972 PT” โ€” vitamin-K-dependent factors 2, 7, 9, 10.
“DubIn-Johnson = Dark Liver” โ€” biopsy is pigmented black.
“Gilbert is Gentle” โ€” mild unconjugated hyperbilirubinemia; otherwise normal LFTs.
“The vowels are excreted, the consonants stay” โ€” Hep A & E are enteric (fecal-oral, no chronic). B, C, D = blood-borne, can become chronic.
“Reye syndrome โ€” aspiRin + viRal illness โ†’ no jaundice but โ†‘ ammonia & โ†‘ AST/ALT”.

Pattern triggers

If you seeโ€ฆ Thinkโ€ฆ Becauseโ€ฆ
AST โ‰ซ ALT (ratio > 2), both < 300 U/L, โ†‘ GGT Alcoholic hepatitis Mitochondrial AST release + B6 deficiency suppressing ALT.
ALT โ‰ซ AST, both > 1000 U/L Acute viral hepatitis or toxin Massive cytosolic enzyme leak from hepatocyte injury.
AST & ALT > 100ร— ULN, AST > ALT, โ†‘ PT early Acetaminophen or ischemic hepatitis Centrilobular necrosis; AST higher initially because of faster release.
โ†‘ ALP & โ†‘ GGT, modest AST/ALT, โ†‘ direct bilirubin Cholestasis (intra- or extrahepatic) Bile-acid action on canalicular membrane.
โ†‘ ALP, normal GGT & 5′-NT Bone, growth spurt, or pregnancy Non-hepatic ALP sources.
โ†‘ Indirect bilirubin only, normal LFTs, normal hemoglobin Gilbert syndrome Reduced UGT1A1 activity (~30%).
โ†‘ Indirect bilirubin + anemia + โ†‘ LD + โ†‘ retic count Hemolysis Excess heme overwhelms hepatic conjugation.
โ†‘ Direct bilirubin + bilirubin in urine + dark urine + clay stool Posthepatic obstruction Conjugated bilirubin water-soluble, refluxes into blood and is filtered by kidney.
Child + viral illness + aspirin + vomiting + โ†‘ AST/ALT + โ†‘ NHโ‚ƒ, no jaundice Reye syndrome Mitochondrial damage to liver and brain.
โ†“ Ceruloplasmin + neuro signs + Kayser-Fleischer rings Wilson disease ATP7B mutation โ†’ copper accumulation.

Side-by-side: commonly confused

Comparison Key distinction
Dubin-Johnson vs Rotor Both: โ†‘ conjugated bilirubin. Dubin-Johnson = black liver. Rotor = normal-appearing liver.
Gilbert vs Crigler-Najjar Both: โ†‘ unconjugated. Gilbert = mild, benign. Crigler-Najjar I = severe, kernicterus risk.
Hemolytic vs hepatic jaundice Hemolytic: โ†‘ indirect only, โ†‘ LD, โ†“ Hgb, no bilirubin in urine. Hepatic: mixed pattern + โ†‘ AST/ALT.
ALP-bone vs ALP-liver Bone: ALP up, GGT & 5′-NT normal, โ†‘ in growth/Paget. Liver: ALP, GGT, 5′-NT all up.
HBV acute vs chronic Acute: IgM anti-HBc positive. Chronic: HBsAg >6 months, IgM anti-HBc negative, IgG anti-HBc positive.
Vaccinated vs naturally immune Vaccinated: anti-HBs only. Recovered: anti-HBs AND anti-HBc.

Diagnostic-window timeline (time-based markers)

Marker Onset Peak Duration Best use
AST (cytosolic) Hours 24โ€“48 h 5โ€“7 d Acute injury detection.
ALT (cytosolic) Hours 24โ€“48 h 2โ€“6 wk More liver-specific; longer half-life โ†’ persists longer.
ALP (hepatic) 1โ€“2 d 3โ€“7 d Up to weeks Tracking cholestasis.
HBsAg 1โ€“10 wk post-exposure โ€” Clears in 6 mo (acute); persists in chronic First serologic marker of HBV.
IgM anti-HBc ~1 mo post-exposure โ€” 4โ€“6 mo Marker of acute HBV; covers window.
Anti-HBs Months โ€” Lifelong (after recovery) Marker of immunity (recovery or vaccine).
IgM anti-HAV Onset of illness โ€” 3โ€“6 mo Diagnose acute HAV.
IgG anti-HAV Weeksโ€“months โ€” Lifelong Past infection or immunity.
Anti-HCV 4โ€“10 wk post-exposure โ€” Years Screening; confirm with HCV RNA.

4 ยท Diagnostic Flowcharts

Flowchart 1 โ€” Jaundice differential

Adult with jaundice โ†’ measure total & direct bilirubin
โ†“
Indirect > 80%? โ†’ Check Hgb, retic, LD, haptoglobin โ†’ โ†“ Hgb + โ†‘ LD + โ†‘ retic = Hemolysis. Normal Hgb + mild โ†‘ indirect + normal LFTs = Gilbert syndrome.
โ†“ if direct elevated
Mixed/Direct rise? โ†’ Check ALT, AST, ALP.
โ†“
ALT/AST โ‰ซ ALP โ†’ Hepatocellular: viral, drug, alcohol, autoimmune. | ALP/GGT โ‰ซ AST/ALT โ†’ Cholestatic: image biliary tree (US/MRCP). Stone or stricture = posthepatic.
โ†“
End: classify as prehepatic, hepatocellular, or cholestatic โ†’ drive next test.
โš ๏ธ Common mistake: Calling all conjugated hyperbilirubinemia “obstruction.” Dubin-Johnson and severe hepatocyte injury also raise direct bilirubin without a duct stone.

Flowchart 2 โ€” Hepatocellular vs cholestatic pattern

Abnormal LFT panel
โ†“
Compute R-ratio = (ALT/ULN) รท (ALP/ULN)
โ†“
R > 5 โ†’ Hepatocellular (viral, drug, ischemic, autoimmune) | R < 2 โ†’ Cholestatic (stones, PBC, drug) | R 2โ€“5 โ†’ Mixed
โ†“
If cholestatic, confirm hepatic ALP with GGT or 5′-NT. If both normal โ†’ bone/placenta ALP, not liver.
โš ๏ธ Common mistake: Ordering only ALT/AST and missing cholestasis. ALP and bilirubin rise more slowly โ€” early obstruction can mimic hepatitis.

Flowchart 3 โ€” HBV serology decision tree

Patient with suspected HBV โ†’ order HBsAg + Anti-HBs + Anti-HBc total
โ†“
HBsAg + โ†’ Active infection. Order IgM anti-HBc โ†’ positive = acute, negative = chronic. Order HBeAg + HBV DNA โ†’ assess infectivity & replication.
โ†“ if HBsAg โˆ’
Anti-HBs +, Anti-HBc + โ†’ Recovered, immune. Anti-HBs + only โ†’ Vaccinated. Anti-HBc + only โ†’ Window period / low-level chronic โ€” repeat in 3โ€“6 months and consider HBV DNA.
โš ๏ธ Common mistake: Confusing vaccination immunity (anti-HBs only) with past infection (anti-HBs + anti-HBc). Anti-HBc never appears from a vaccine.

Flowchart 4 โ€” Choosing the right marker for โ†‘ ALP

Asymptomatic โ†‘ ALP
โ†“
Add GGT (preferred) or 5′-nucleotidase.
โ†“
Both โ†‘ โ†’ Hepatobiliary disease โ†’ image biliary tree, check AMA (PBC), drug history. | Only ALP โ†‘ โ†’ Bone disease (Paget, mets, growth), pregnancy (3rd trimester placenta), or benign familial ALP.
โš ๏ธ Common mistake: Rushing the ultrasound before differentiating bone from liver. A pregnant 32-year-old with โ†‘ ALP and normal GGT does NOT need an MRCP.

Flowchart 5 โ€” Prolonged PT in liver disease

Prolonged PT/INR in jaundiced patient
โ†“
Give parenteral vitamin K 10 mg โ†’ recheck PT in 24โ€“48 h.
โ†“
PT corrects โ†’ Cholestasis (fat-soluble vitamin malabsorption). PT does NOT correct โ†’ Hepatocellular synthetic failure โ€” poor prognosis.
โš ๏ธ Common mistake: Reporting INR alone in chronic liver disease. INR was standardized for warfarin, not hepatic coagulopathy โ€” calculate a liver-specific INR if available.

5 ยท 25 High-Yield Facts

# Fact
1 Liver is the only organ that conjugates bilirubin; UDP-glucuronyl transferase (UGT1A1) is the key enzyme.
2 Conjugated (direct) bilirubin is water-soluble and appears in urine; unconjugated does not.
3 Visible jaundice appears at bilirubin โ‰ฅ3 mg/dL.
4 Adult total bilirubin reference: 0.2โ€“1.0 mg/dL.
5 Jendrassik-Grof reference method uses caffeine-benzoate accelerator and reads azobilirubin at 600 nm.
6 Bilirubin is destroyed by light โ€” protect samples; 30โ€“50% loss per hour in fluorescent light.
7 Hemolysis decreases the diazo reaction and falsely lowers bilirubin.
8 Delta bilirubin = conjugated bilirubin covalently bound to albumin; reads as direct on most analyzers.
9 ALT is more liver-specific than AST.
10 AST/ALT ratio >2 (De Ritis) suggests alcoholic liver disease.
11 In viral hepatitis, ALT > AST and both can exceed 1000 U/L.
12 ALP >300 U/L with jaundice suggests biliary obstruction.
13 โ†‘ ALP + normal GGT/5′-NT โ†’ think bone, growth spurt, or pregnancy, not liver.
14 EDTA chelates zinc and falsely lowers ALP โ€” use lithium heparin or serum.
15 Albumin half-life is ~21 days โ†’ falls only in chronic disease (cirrhosis).
16 Vitamin Kโ€“dependent factors are II, VII, IX, X (and proteins C and S).
17 Vitamin K corrects PT in cholestasis but NOT in hepatocellular failure.
18 Ammonia must be collected in EDTA/heparin, kept on ice, hemolysis-free (RBC ammonia is 2โ€“3ร— plasma).
19 Reye syndrome = pediatric encephalopathy + fatty liver + โ†‘ ammonia + โ†‘ aminotransferases, NO jaundice; aspirin trigger.
20 Gilbert syndrome: mild unconjugated hyperbilirubinemia (UGT1A1 promoter), benign, fluctuating with fasting.
21 Dubin-Johnson: conjugated hyperbilirubinemia + black liver on biopsy.
22 Wilson disease: โ†“ ceruloplasmin, โ†‘ urine copper, Kayser-Fleischer rings, ALP:bilirubin <4 in fulminant form.
23 Hemochromatosis: HFE C282Y, โ†‘ transferrin saturation >45%, โ†‘ ferritin.
24 IgM anti-HBc is the marker of acute HBV โ€” covers the serologic window when HBsAg has cleared.
25 ฮฑ-fetoprotein >500 ng/mL in a cirrhotic patient strongly suggests HCC.
EXAM TIP โ€” The single most testable pattern: Given an LFT panel, first determine the pattern (hepatocellular vs cholestatic), then the chronicity (acute vs chronic), then the etiology (viral/toxic/metabolic). ASCP rewards this three-step logic over rote memorization.

Quick Interpretation Table

Lab Finding Clinical Interpretation
Total bili 4 mg/dL, indirect 90%, โ†‘ LD, โ†“ Hgb Hemolysis (prehepatic jaundice).
AST 1500, ALT 2200, ALP 180, direct bili 6 mg/dL Acute viral hepatitis (hepatocellular pattern).
AST 220, ALT 90, GGT 600, MCV 102 Alcoholic liver disease (De Ritis > 2).
ALP 900, GGT 450, direct bili 12 mg/dL, clay stool Posthepatic / biliary obstruction.
ALT 60, ALP 950, GGT normal, child age 8 Bone growth โ€” not liver disease.
HBsAg +, IgM anti-HBc +, HBeAg + Acute HBV, highly infectious.
HBsAg +, IgM anti-HBc โˆ’, HBeAg โˆ’, anti-HBe + Inactive chronic HBV carrier (low infectivity).
Total bili 3, indirect 95%, normal LFTs, fasting precipitated Gilbert syndrome.

6 ยท Practice Questions (Patient Scenarios)

๐Ÿ“ Practice Quiz โ€” Test Your Knowledge

Click an answer for each question. You’ll get instant feedback with a detailed explanation. Your final score appears at the end. Good luck!
0 OF 10 ANSWERED
Question 1 of 10

A 45-year-old man with a long history of alcohol use presents with jaundice and ascites. Labs: AST 240 U/L, ALT 95 U/L, GGT 580 U/L, ALP 220 U/L, total bilirubin 4.2 mg/dL, albumin 2.6 g/dL, INR 1.8. Which pattern best fits these findings?
Question 2 of 10

A 28-year-old woman returning from Mexico develops malaise, nausea, dark urine, and scleral icterus. Total bili 6.1 mg/dL (mostly direct), ALT 1850, AST 1420, ALP 145. Which test confirms the most likely diagnosis?
Question 3 of 10

A 6-year-old boy recovering from influenza, treated with aspirin, develops vomiting and progressive lethargy. Labs: AST 480, ALT 420, total bilirubin 1.2 mg/dL, ammonia 220 ยตg/dL, glucose 55 mg/dL. The most likely diagnosis is:
Question 4 of 10

A neonate at 3 days of life has total bilirubin 18 mg/dL, almost all indirect, with no hemolysis. Which enzyme is most likely deficient?
Question 5 of 10

A nurse with a needlestick injury 8 weeks ago presents for testing. Results: HBsAg negative, anti-HBs negative, anti-HBc total positive, IgM anti-HBc positive. Which is most accurate?
Question 6 of 10

A 35-year-old woman presents for evaluation of a tremor. Labs: AST 180, ALT 220, ALP 38 U/L (low), bilirubin 4.0 mg/dL, ceruloplasmin 12 mg/dL (low). ALP/bilirubin ratio is <4. The diagnosis is:
Question 7 of 10

A 60-year-old man with cirrhosis develops a new 4-cm liver mass on imaging. Which tumor marker best supports hepatocellular carcinoma?
Question 8 of 10

A college student has chronic mildly elevated unconjugated bilirubin (2.5 mg/dL) noted on routine screening. Hgb, AST, ALT, ALP, and reticulocytes are all normal. Fasting precipitates the elevation. Most likely:
Question 9 of 10

A 70-year-old woman has isolated ALP elevation at 480 U/L. AST, ALT, bilirubin, GGT, and 5โ€ฒ-nucleotidase are all normal. The next best step is:
Question 10 of 10

A lab tech is processing an ammonia level from a patient with suspected hepatic encephalopathy. Which step is INCORRECT?

๐ŸŽ‰ Quiz Complete!

Your Score
0 / 10
0%

7 ยท Trap Questions (7 Hardest Misconceptions)

๐Ÿชค Trap Quiz โ€” Can You Avoid the Pitfalls?

These are the 7 trickiest questions on this chapter. Each targets a classic misconception tested on the ASCP exam. Click an answer โ€” instant feedback included. Good luck!
0 OF 7 ANSWERED
Trap 1 of 7

A 32-year-old pregnant woman in her third trimester has an ALP of 320 U/L. AST, ALT, and bilirubin are normal. The most appropriate next step is:
Trap 2 of 7

A patient with biliary obstruction has prolonged PT. After 10 mg of parenteral vitamin K, PT normalizes within 24 hours. This indicates:
Trap 3 of 7

A serum bilirubin sent in a clear glass tube sat under a window for 3 hours before testing. Compared to a properly stored sample, the measured bilirubin will be:
Trap 4 of 7

Lab test results: HBsAg negative, anti-HBs positive, anti-HBc negative. This patient is best classified as:
Trap 5 of 7

A patient on phenytoin and chronic alcohol has GGT 350 U/L, ALP normal, AST 38, ALT 32, bilirubin 0.9 mg/dL. This pattern most likely reflects:
Trap 6 of 7

A 24-year-old previously healthy man took 25 g of acetaminophen 48 hours ago. INR 4.2, AST 8400, ALT 5800, total bilirubin 4.5, creatinine 2.1. Which is the MOST important prognostic marker?
Trap 7 of 7

A 4-month-old infant has persistent direct hyperbilirubinemia, acholic stools, and a low ฮฑ1-globulin band on serum protein electrophoresis. Which is the most likely diagnosis?

๐ŸŽ‰ Trap Quiz Complete!

Your Score
0 / 7
0%

8 ยท Rapid Revision Sheet

๐Ÿ“– READ THIS 2 HOURS BEFORE YOUR EXAM

Bilirubin numbers
  • Total: 0.2โ€“1.0 mg/dL
  • Conjugated: 0.0โ€“0.2
  • Visible jaundice: โ‰ฅ3 mg/dL
  • Kernicterus risk: โ‰ฅ20 mg/dL (neonate)
  • Gilbert: 1.5โ€“3 mg/dL (rarely >4.5)
Enzyme half-lives
  • AST: 17 h
  • ALT: 47 h
  • ALP (liver): 1โ€“7 days
  • GGT: ~4 days
  • Factor VII: 4โ€“6 h (PT sensitivity)
Always-together pairs
  • โ†‘ ALP + โ†‘ GGT โ†’ liver
  • โ†‘ ALP + โ†‘ 5'-NT โ†’ liver
  • โ†‘ ALP alone โ†’ bone/placenta
  • โ†‘ Direct bili + bili in urine
  • โ†‘ Indirect bili + โ†‘ LD + โ†“ Hgb โ†’ hemolysis
Opposites
  • ALT > AST = viral / NAFLD
  • AST > ALT (>2) = alcohol
  • Vit K corrects โ†’ cholestasis
  • Vit K fails โ†’ hepatocellular
  • IgM = acute; IgG = past
Bilirubin methods
  • Jendrassik-Grof: caffeine-benzoate, 600 nm, blue
  • Malloy-Evelyn: methanol, 560 nm, red-purple, pH 1.2
  • Direct = no accelerator
  • Light degrades 30โ€“50%/hr
  • Hemolysis โ†“ bili
Ammonia rules
  • EDTA / Li-heparin / K-oxalate
  • NEVER red-top
  • Ice immediately
  • Reject hemolysis (RBC 2โ€“3ร— plasma)
  • Ref: 15โ€“45 ยตg/dL
HBV serology shortcuts
  • Acute: HBsAg + IgM anti-HBc +
  • Chronic: HBsAg >6 mo, IgG anti-HBc +
  • Recovered: anti-HBs + anti-HBc
  • Vaccinated: anti-HBs only
  • Window: IgM anti-HBc only
Inherited jaundice
  • Gilbert โ†’ โ†‘ indirect, mild
  • Crigler-Najjar I โ†’ severe โ†‘ indirect, kernicterus
  • Dubin-Johnson โ†’ โ†‘ direct, BLACK liver
  • Rotor โ†’ โ†‘ direct, normal liver
  • Physiologic newborn โ†’ immature UGT
Confusing pairs
  • Anti-HBs alone vs +anti-HBc (vaccine vs recovery)
  • Direct vs total bilirubin (direct = without accelerator)
  • AST/ALT ratio >2 vs <1 (alcohol vs viral)
  • ALP-bone vs ALP-liver (GGT confirms)
  • Dubin-Johnson vs Rotor (black liver vs normal)
Metabolic disease keys
  • Wilson โ†’ โ†“ ceruloplasmin, KF rings, โ†‘ urine Cu, ALP:bili <4
  • Hemochromatosis โ†’ HFE C282Y, TS >45%, โ†‘ ferritin
  • AAT def โ†’ PiZZ, โ†“ ฮฑ1 on SPE
  • Reye โ†’ ASA + viral kid, โ†‘ NHโ‚ƒ, โ†‘ AST/ALT, no jaundice
  • HCC โ†’ cirrhosis + โ†‘ AFP >500
Hepatitis quick rules
  • A & E โ†’ fecal-oral, no chronic
  • B โ†’ DNA, can be chronic
  • C โ†’ RNA, often chronic
  • D โ†’ needs HBV
  • E โ†’ severe in pregnancy
Pre-analytical traps
  • EDTA โ†’ falsely low ALP (Zn chelation)
  • Hemolysis โ†’ โ†‘ AST, โ†‘ NHโ‚ƒ
  • BCG โ†’ โ†‘ albumin (low end)
  • BCP โ†’ โ†“ albumin in jaundice
  • Light โ†’ โ†“ bilirubin

9 ยท Final Memory Map

LIVER FUNCTION & LIVER DISEASE
โ–ธ Bilirubin Pathway
RBC heme โ†’ unconjugated (albumin-bound) โ†’ hepatocyte uptake (ligandin) โ†’ UGT1A1 conjugation โ†’ bile โ†’ urobilinogen (gut) โ†’ stercobilin (feces) / small amount in urine
Adult: 0.2โ€“1.0 mg/dL ยท Visible jaundice โ‰ฅ3 mg/dL ยท Kernicterus โ‰ฅ20 mg/dL (neonate)
Methods: Jendrassik-Grof (caffeine-benzoate, 600 nm) โ€” reference; Malloy-Evelyn (methanol, 560 nm)
Delta bilirubin = conjugated + albumin (long-lived)
โ–ธ Jaundice Classification
Prehepatic โ†’ hemolysis โ†’ โ†‘ indirect, โ†‘ LD, โ†“ Hgb, NO urine bilirubin
Hepatic โ†’ Gilbert / Crigler-Najjar (โ†‘ indirect); Dubin-Johnson / Rotor (โ†‘ direct); physiologic newborn
Posthepatic โ†’ stones, tumors โ†’ โ†‘ ALP/GGT, โ†‘ direct bili, clay stool, dark urine
โ–ธ Enzyme Patterns
Hepatocellular: ALT > AST (viral), AST > ALT (alcohol โ€” De Ritis >2)
Cholestatic: ALP โ‰ซ AST/ALT + GGT or 5'-NT confirms hepatic origin
LD non-specific, useful for hemolysis or mets
โ–ธ Synthetic Function
Albumin (~21-day half-life) โ†’ chronic disease marker
PT/INR โ†’ most sensitive acute marker; factor VII shortest half-life (~4โ€“6 h)
Vit K trial differentiates cholestasis (corrects) from hepatocellular failure (does not)
1972 = vitamin K factors II, VII, IX, X
โ–ธ Nitrogen Metabolism โ€” Ammonia
GI bacteria โ†’ portal vein โ†’ liver urea cycle โ†’ kidney
โ†‘ in cirrhosis, hepatic encephalopathy, Reye, urea-cycle errors
Plasma in EDTA/Li-heparin, ICE immediately, reject hemolysis
โ–ธ Viral Hepatitis
A โ€” RNA, fecal-oral, IgM anti-HAV diagnoses acute
B โ€” DNA, parenteral, HBsAg first; IgM anti-HBc = acute, anti-HBs = immunity
C โ€” RNA, parenteral, anti-HCV + HCV RNA
D โ€” defective, requires HBV (coinfection vs superinfection)
E โ€” RNA, fecal-oral, severe in pregnancy
โ–ธ Inherited & Metabolic
Wilson: โ†“ ceruloplasmin, โ†‘ urine Cu, KF rings, ALP:bili <4
Hemochromatosis: HFE C282Y, โ†‘ TS, โ†‘ ferritin
ฮฑ1-AT deficiency: PiZZ, โ†“ ฮฑ1 on SPE
โ–ธ Other Key Conditions
Reye: aspirin + viral illness, โ†‘ NHโ‚ƒ, โ†‘ AST/ALT, no jaundice
Alcoholic hepatitis: AST/ALT >2, โ†‘ GGT, โ†“ albumin, โ†‘ INR
Acetaminophen: AST > ALT, very high values, glutathione depletion
HCC: cirrhotic + โ†‘ ฮฑ-fetoprotein >500 ng/mL
Cirrhosis: โ†“ albumin, โ†‘ INR, โ†“ platelets, MELD/Child-Pugh scoring

๐ŸŽด Flashcards โ€” Active Recall Practice

Click the card to flip and reveal the answer. Mark each card as Knew it โœ“ or Review again โœ— to track your progress. Click ๐Ÿ”€ Shuffle to randomize the deck. Your final summary appears when you finish or reach the last card.
Card 1 of 100โœ“ Knew: 0โœ— Missed: 0
Question

Answer

Click card to reveal answer
๐ŸŽ‰ Session Complete!
0โœ“ Knew
0โœ— Missed
0Unmarked
0% Recall

PreviousNext